Abstract B067: Agonistic CD137 (4-1BB) anchored immunotherapy (ANK-203) elicits potent 4-1BBL signaling in vitro and therapeutic responses against established tumors without systemic toxicity in vivo
Year: 2026
Type: conference-abstract
Source: Cancer Immunology Research
Authors: Robert G. Newman, Kanika Jain, Howard L. Kaufman, Sailaja Battula
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7130394111
Cites:
Cited by:
Related to: